Single dose myocardial protection technique utilizing del Nido cardioplegia solution during congenital heart surgery procedures

Perfusion

Volumn 27, Issue 2, 2012, Pages 98-103

  Charette, K ^a   Gerrah, R ^a   Quaegebeur, J ^a   Chen, J ^a   Riley, D ^a   Mongero, L ^a   Corda, R ^a   Bacha, E ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT; DEL NIDO SOLUTION; GLUCOSE; UNCLASSIFIED DRUG;

AORTA CLAMPING; ARTICLE; BLOOD TRANSFUSION; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; COMPLETE HEART BLOCK; CONGENITAL HEART SURGERY; GLUCOSE BLOOD LEVEL; HEART PROTECTION; HEART SURGERY; HUMAN; PEDIATRICS; PRIORITY JOURNAL; SINGLE DRUG DOSE; SURGICAL TECHNIQUE;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CARDIOPLEGIC SOLUTIONS; CARDIOPULMONARY BYPASS; CHILD; HEART ARREST, INDUCED; HEART DEFECTS, CONGENITAL; HUMANS; INCIDENCE; MYOCARDIUM; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 84863386098     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659111424788     Document Type: Article

References (17)

1. Castenada A, Jonas R, Mayer J, Hanley F Cardiac surgery of the neonate and infant. Castenada A Jonas R Mayer J Hanley F, ed. Philadelphia: W.B. Saunders Company ; 1994: 41-55.
2. Corell R. Milestones in the development of cardioplegia. Ann Thorac Surg. 1995 ; 60: 793-796
3. Reed C, Stafford T Cardiopulmonary Bypass. Reed C Stafford T, ed. Woodlands, TX: Sugimedicus/TMP ; 1985: 415-427.
4. Gravlee G, Davis F, Kurusz M, Utley J Cardiopulmonary bypass principles and practice. Philadelphia: Lippincott Williams and Wilkins ; 2000: 214-264.
5. Jonas R New York: Oxford University Press ; 2004: 175-185.
6. O'Brien J, Howlett S, Burton H, O'Bluens S. Pediatric cardioplegia strategy results in enhanced calcium metabolism and lower serum troponin t. Ann Thorac Surg. 2009 ; 87: 1517-1523
7. del Nido P, Wilson G, Mickle D. The role of cardioplegic solution buffering in myocardial protection. A biochemical and histopathological assessment. J Thorac Cardiovasc Surg. 1985 ; 89: 689-699 (Pubitemid 16241960)
8. Rebeyka I, Axford-Gatley R, Bush B, et al. Calcium paradox in an in vivo model of mutidose cardioplegia and moderate hypothermia. Prevention with diltiazem or trace calcium levels. J Thorac Cardiovasc Surg. 1990 ; 99: 475-483 (Pubitemid 20097774)
9. Ohkado A, Cao-Danh H, Sommers E, del Nido P. Evaluation of highly buffered low-calcium solution for long-term preservation of the heart. Comparison with University of Wisconsin solution. J Thorac Cardiovasc Surg. 1994 ; 108: 762-771 (Pubitemid 24330256)
10. Piper H. The calcium paradox revisited: an artifact of great heuristic value. Cardiovasc Res 2000. 45: 123-127
11. Jenkins K, Gauvreau K, Newburger J. Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg. 2002 ; 123: 110-118.
12. Ibrahim MF, Venn GE, Young CP. A clinical comparative study between crystalloid and blood-based St Thomas' hospital cardioplegic solution. Eur J Cardiothorac Surg. 1999 ; 15: 75-83 (Pubitemid 29084555)
13. Kong J, Kim H, Chang B. Comparison of cardioprotection between HTK cardioplegia and del Nido cardioplegia in isolated rat hearts. Korean J Thorac Cardiovasc Surg. 2003 ; 36: 799-811
14. Asano H, Kyo S, Ogiwara M, Tsunemoto M. Single-dose and high-volume Bretschneider cardioplegic solution for congenital heart surgery. Kyobu Geka. 1999 ; 52 (1). 82-86
15. Wollenek G, Windischbauer A. Myocardial protection with Bretschneider cardioplegic solution-an evaluation of full oxygenation. Eur Surg Res. 1994 ; 26: 133-140 (Pubitemid 24091730)
16. O'Blenes S, Friesen C, Ali A, Howlett S. Protecting the aged heart during cardiac surgery: the potential benefits of del Nido cardioplegia. J Thorac Cardiovasc Surg. 2011 ; 3: 762-770
17. Baies M, Gurney J, Yen A, et al. Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass. Pediatr Crit Care Med. 2010 ; 2: 234-238.